DS
TARO

David Shaw’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

David Shaw’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,000
Closed -$282K – 3909
2015
Q1 		$282K Hold
2,000
– – ﹤0.01% 3330
2014
Q4 		$296K Hold
2,000
– – ﹤0.01% 3648
2014
Q3 		$308K Buy
+2,000
New +$301K ﹤0.01% 3678

Other funds holding TARO

KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

David Shaw's TARO Position: Q1 2024 in Review

David Shaw sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2024, closing a stake of 10,345 shares — an estimated $432K sold.

David Shaw first reported a position in TARO in Q2 2013 and held it in 34 quarters. The position peaked at $8.11M in Q4 2019. 94 funds tracked by Wall St. Rank hold TARO as of Q1 2024.

  • David Shaw reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2024 after selling out during the quarter.
  • David Shaw sold 10,345 Taro Pharmaceutical Industries Ltd. shares in Q1 2024, an estimated $432K.
  • David Shaw first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and held it in 34 quarters.
  • David Shaw's Taro Pharmaceutical Industries Ltd. position peaked at $8.11M in Q4 2019.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.